Microscopic polyangiitis following recurrent Staphylococcus aureus bacteremia and infectious endocarditis. 2006

J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
Rheumatology Division, Hospital Xeral-Calde, Lugo, Spain.

Secondary vasculitis resulting from unusual pathologic expressions of infections has been described and has important clinical significance. Infectious agents have also been implicated in the pathogenesis of different primary systemic necrotizing vasculitides. Infectious endocarditis is of particular importance in the differential diagnosis of a patient presenting with ANCA associated vasculitis. We report a well-documented case of a patient with recurrent Staphylococcus aureus bacteremia who developed bacterial endocarditis and also fulfilled the Chapel Hill Conference definitions for microscopic polyangiitis. To the best of our knowledge, it is the second case of bacterial endocarditis associated with both pANCA and anti-MPO specificity that fulfilled definitions for systemic necrotizing vasculitis. We emphasize the potential pathogenic role of infection as the trigger factor for the development of systemic vasculitis.

UI MeSH Term Description Entries
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D014657 Vasculitis Inflammation of any one of the blood vessels, including the ARTERIES; VEINS; and rest of the vasculature system in the body. Angiitis,Angiitides,Vasculitides
D016470 Bacteremia The presence of viable bacteria circulating in the blood. Fever, chills, tachycardia, and tachypnea are common acute manifestations of bacteremia. The majority of cases are seen in already hospitalized patients, most of whom have underlying diseases or procedures which render their bloodstreams susceptible to invasion. Bacteremias
D019268 Antibodies, Antineutrophil Cytoplasmic Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA. ANCA,Anti-Neutrophil Cytoplasmic Autoantibodies,Anti-Neutrophil Cytoplasmic Autoantibody,Antineutrophil Cytoplasmic Antibodies,Neutrophil Cytoplasmic Autoantibodies,Neutrophil Cytoplasmic Autoantibody,c-ANCA,p-ANCA,Anti-Neutrophil Cytoplasmic Antibodies,Anti-Neutrophil Cytoplasmic Antibody,Antineutrophil Cytoplasmic Antibody,Anti Neutrophil Cytoplasmic Antibodies,Anti Neutrophil Cytoplasmic Antibody,Anti Neutrophil Cytoplasmic Autoantibodies,Anti Neutrophil Cytoplasmic Autoantibody,Antibody, Anti-Neutrophil Cytoplasmic,Antibody, Antineutrophil Cytoplasmic,Autoantibody, Anti-Neutrophil Cytoplasmic,Autoantibody, Neutrophil Cytoplasmic,Cytoplasmic Antibody, Anti-Neutrophil,Cytoplasmic Antibody, Antineutrophil,Cytoplasmic Autoantibody, Anti-Neutrophil,Cytoplasmic Autoantibody, Neutrophil,c ANCA,p ANCA

Related Publications

J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
September 2010, International urology and nephrology,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
June 2002, Infectious disease clinics of North America,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
May 2003, Cardiology clinics,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
April 2008, Annales de cardiologie et d'angeiologie,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
June 2000, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
March 1992, Journal of clinical microbiology,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
April 2024, Cureus,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
January 2015, JAMA,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
November 1982, The American journal of medicine,
J A Miranda-Filloy, and J A Veiga, and Y Juarez, and C Gonzalez-Juanatey, and M A Gonzalez-Gay, and C Garcia-Porrua
January 2017, Current topics in microbiology and immunology,
Copied contents to your clipboard!